Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Pomponio RJ, Reynolds TR, Cole H, Buck GA, Wolf B : Mutational hotspot in the human biotinidase gene causes profound biotinidase deficiency. Nat Genet 1995; 11: 96–98.
Pindolia K, Jordan M, Wolf B : Analysis of mutations causing biotinidase deficiency. Human mutation 2010; 31: 983–991.
Procter M, Wolf B, Crockett DK, Mao R : The Biotinidase Gene Variants Registry. A Paradigm Public Database. G3 (Bethesda) 2013; 3: 727–731.
Wolf B : Biotinidase deficiency: ‘if you have to have an inherited metabolic disease, this is the one to have’. Genetics in medicine: official journal of the American College of Medical Genetics 2012; 14: 565–575.
Li H, Spencer L, Nahhas F et al: Novel mutations causing biotinidase deficiency in individuals identified by newborn screening in Michigan including an unique intronic mutation that alters mRNA expression of the biotinidase gene. Molecular genetics and metabolism 2014; 112: 242–246.
Senanayake DN, Jasinge EA, Pindolia K et al: First contiguous gene deletion causing biotinidase deficiency: The enzyme deficiency in three Sri Lankan children. Molecular Genetics and Metabolism Reports 2015; 2: 81–84.
Wolf B : Worldwide survey of neonatal screening for biotinidase deficiency. Journal of inherited metabolic disease 1991; 14: 923–927.
Norrgard KJ, Pomponio RJ, Swango KL et al: Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States. Biochem Mol Med 1997; 61: 22–27.
Pomponio RJ, Hymes J, Reynolds TR et al: Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical, and clinical analysis. Pediatr Res 1997; 42: 840–848.
Wolf B Biotinidase deficiencyin: Pagon RA, Bird TD, Dolan CR (eds): GeneReviews [Internet]. University of Washington: Seattle: Seattle (WA), 1993–2013, [Last Update 2013].
Dobrowolski SF, Angeletti J, Banas RA, Naylor EW : Real time PCR assays to detect common mutations in the biotinidase gene and application of mutational analysis to newborn screening for biotinidase deficiency. Molecular genetics and metabolism 2003; 78: 100–107.
Iqbal F, Item CB, Vilaseca MA et al: The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC). Molecular genetics and metabolism 2010; 100: 42–45.
Cowan TM, Blitzer MG, Wolf B : Technical standards and guidelines for the diagnosis of biotinidase deficiency. Genetics in medicine: official journal of the American College of Medical Genetics 2010; 12: 464–470.
Thodi G, Molou E, Georgiou V et al: Mutational analysis for biotinidase deficiency of a Greek patients' cohort ascertained through expanded newborn screening. J Hum Genet 2011; 56: 861–5.
Norrgard KJ, Pomponio RJ, Swango KL et al: Double mutation (A171T and D444H) is a common cause of profound biotinidase deficiency in children ascertained by newborn screening the the United States. Mutations in brief no. 128. Online. Human mutation 1998; 11: 410.
Loeber JG : Neonatal screening in Europe; the situation in 2004. Journal of inherited metabolic disease 2007; 30: 430–438.
Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL : Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Clin Chim Acta 1983; 131: 273–281.
Wolf B : Why screen newborns for profound and partial biotinidase deficiency? Molecular genetics and metabolism 2015; 114: 382–387.
Bottin L, Prud’hon S, Guey S et al: Biotinidase deficiency mimicking neuromyelitis optica: initially exhibiting symptoms in adulthood. Mult Scler 2015; 21: 160–167.
McVoy JR, Levy HL, Lawler M et al: Partial biotinidase deficiency: clinical and biochemical features. J Pediatr 1990; 116: 78–83.
Suormala TM, Baumgartner ER, Wick H, Scheibenreiter S, Schweitzer S : Comparison of patients with complete and partial biotinidase deficiency: biochemical studies. Journal of inherited metabolic disease 1990; 13: 76–92.
Baykal T, Gokcay G, Gokdemir Y et al: Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases. Journal of inherited metabolic disease 2005; 28: 903–912.
Muhl A, Moslinger D, Item CB, Stockler-Ipsiroglu S : Molecular characterisation of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation. Eur J Hum Genet 2001; 9: 237–243.
Wolf B : Clinical issues and frequent questions about biotinidase deficiency. Molecular genetics and metabolism 2010; 100: 6–13.
Neto EC, Schulte J, Rubim R et al: Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations. Brazilian journal of medical and biological research=Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al] 2004; 37: 295–299.
Ohlsson A, Guthenberg C, Holme E, von Dobeln U : Profound biotinidase deficiency: a rare disease among native Swedes. Journal of inherited metabolic disease 2010; 33 (Suppl 3): S175–S180.
Tanzer F, Sancaktar M, Buyukkayhan D : Neonatal screening for biotidinidase deficiency: results of a 1-year pilot study in four cities in central Anatolia. Journal of pediatric endocrinology & metabolism: JPEM 2009; 22: 1113–1116.
Heard GS, Secor McVoy JR, Wolf B : A screening method for biotinidase deficiency in newborns. Clinical chemistry 1984; 30: 125–127.
Jay AM, Conway RL, Feldman GL, Nahhas F, Spencer L, Wolf B : Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years. Genetics in medicine: official journal of the American College of Medical Genetics 2015; 17: 205–209.
Tezel B, Dilli D, Bolat H et al: The development and organization of newborn screening programs in Turkey. Journal of clinical laboratory analysis 2014; 28: 63–69.
Lara MT, Gurgel-Giannetti J, Aguiar MJ et al: High Incidence of Biotinidase Deficiency from a Pilot Newborn Screening Study in Minas Gerais, Brazil. JIMD reports 2015; 24: 103–107.
Carroll AE, Downs SM : Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics 2006; 117: S287–S295.
Schoos R, Verloes A, Bourguignon JP, Koulischer L : [Programs of systematic screening in neonatology. Pharmaco-economic aspects]. Revue medicale de Liege 1998; 53: 311–315.
Swango KL, Demirkol M, Huner G et al: Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene. Human genetics 1998; 102: 571–575.
Mock DM, Mock NI, Stewart CW, LaBorde JB, Hansen DK : Marginal biotin deficiency is teratogenic in ICR mice. The Journal of nutrition 2003; 133: 2519–2525.
Said HM : Biotin: biochemical, physiological and clinical aspects. Sub-cellular biochemistry 2012; 56: 1–19.
Watanabe T : Teratogenic effects of biotin deficiency in mice. The Journal of nutrition 1983; 113: 574–581.
Zempleni J, Mock DM : Marginal biotin deficiency is teratogenic. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine 2000; 223: 14–21.
Acknowledgements
This work was supported by EuroGentest2 (Unit 2: ‘Genetic testing as part of health care’), a Coordination Action under FP7 (Grant Agreement Number 261469) and the European Society of Human Genetics. In addition, this work was supported by the Safra Research Fund at Henry Ford Hospital.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Küry, S., Ramaekers, V., Bézieau, S. et al. Clinical utility gene card for: Biotinidase deficiency—update 2015. Eur J Hum Genet 24, 3–5 (2016). https://doi.org/10.1038/ejhg.2015.246
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2015.246
